# Bavarian Nordic to invest $75M in fill/finish line in Denmark

Bavarian Nordic will invest approximately USD 75 million over the coming years in the construction of a fill/finish manufacturing line at its facility in Denmark to support the IMVAMUNE stockpile.

- Type: Investment
- Announced: 2017-09-27
- Where: Denmark, Denmark
- Value: $75.0M
- Status: announced
- Products: fill/finish manufacturing line for smallpox vaccine

## Companies

- [Bavarian Nordic](https://endata.com/companies/26366.md)

## Sources

- [biospace.com](https://www.biospace.com/bavarian-nordic-secures-contract-award-for-supply-of-freeze-dried-imvamune-smallpox-vaccine-to-the-u-s-government), 2017-09-28: "Bavarian Nordic will invest approximately USD 75 million over the coming years in the construction of a fill/finish manufacturing line at its facility in Denmark."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.